Skip to main content
. Author manuscript; available in PMC: 2020 Oct 7.
Published in final edited form as: Mol Pharm. 2019 Aug 26;16(10):4302–4312. doi: 10.1021/acs.molpharmaceut.9b00639

Figure 3.

Figure 3.

Comparison of the growth factor composition and miRNA composition of the secretome derived from transfected vs nontransfected hASCs with miR-146a. The group named secretome146a refers to hASCs transfected with the miR-146a. (A) Angiogenic array analysis displaying the difference in the secreted amount of several angiogenic growth factors. (B) qPCR analysis of the main proangiogenic miRNA found in the EVs of the two types of the secretome. (C) qPCR analysis of the main antiangiogenic miRNA found in the EVs of the two types of the secretome.